{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:31:33Z","timestamp":1795026693551,"version":"4.10.2"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T00:00:00Z","timestamp":1626480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T00:00:00Z","timestamp":1626480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Intramural program of NIAAA"],"award-info":[{"award-number":["Intramural program of NIAAA"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Repetitive mild traumatic brain injury (mTBI) can result in chronic visual dysfunction. G-protein receptor 110 (GPR110, ADGRF1) is the target receptor of <jats:italic>N<\/jats:italic>-docosahexaenoylethanolamine (synaptamide) mediating the anti-neuroinflammatory function of synaptamide. In this study, we evaluated the effect of an endogenous and a synthetic ligand of GPR110, synaptamide and (4Z,7Z,10Z,13Z,16Z,19Z)-N-(2-hydroxy-2-methylpropyl) docosa-4,7,10,13,16,19-hexaenamide (dimethylsynaptamide, A8), on the mTBI-induced long-term optic tract histopathology and visual dysfunction using Closed-Head Impact Model of Engineered Rotational Acceleration (CHIMERA), a clinically relevant model of mTBI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The brain injury in wild-type (WT) and GPR110 knockout (KO) mice was induced by CHIMERA applied daily for 3 days, and GPR110 ligands were intraperitoneally injected immediately following each impact. The expression of GPR110 and proinflammatory mediator tumor necrosis factor (TNF) in the brain was measured by using real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) in an acute phase. Chronic inflammatory responses in the optic tract and visual dysfunction were assessed by immunostaining for Iba-1 and GFAP and visual evoked potential (VEP), respectively. The effect of GPR110 ligands <jats:italic>in vitro<\/jats:italic> was evaluated by the cyclic adenosine monophosphate (cAMP) production in primary microglia isolated from adult WT or KO mouse brains.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>CHIMERA injury acutely upregulated the GPR110 and TNF gene level in mouse brain. Repetitive CHIMERA (rCHIMERA) increased the GFAP and Iba-1 immunostaining of glia cells and silver staining of degenerating axons in the optic tract with significant reduction of N1 amplitude of visual evoked potential at up to 3.5 months after injury. Both GPR110 ligands dose- and GPR110-dependently increased cAMP in cultured primary microglia with A8, a ligand with improved stability, being more effective than synaptamide. Intraperitoneal injection of A8 at 1 mg\/kg or synaptamide at 5 mg\/kg significantly reduced the acute expression of TNF mRNA in the brain and ameliorated chronic optic tract microgliosis, astrogliosis, and axonal degeneration as well as visual deficit caused by injury in WT but not in GPR110 KO mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our data demonstrate that ligand-induced activation of the GPR110\/cAMP system upregulated after injury ameliorates the long-term optic tract histopathology and visual impairment caused by rCHIMERA. Based on the anti-inflammatory nature of GPR110 activation, we suggest that GPR110 ligands may have therapeutic potential for chronic visual dysfunction associated with mTBI.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12974-021-02195-y","type":"journal-article","created":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T16:02:38Z","timestamp":1626537758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["GPR110 ligands reduce chronic optic tract gliosis and visual deficit following repetitive mild traumatic brain injury in mice"],"prefix":"10.1186","volume":"18","author":[{"given":"Huazhen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Kevala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elma","family":"Aflaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Marugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5546-8052","authenticated-orcid":false,"given":"Hee-Yong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,17]]},"reference":[{"issue":"2","key":"2195_CR1","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1089\/neu.2016.4446","volume":"34","author":"JF Strain","year":"2017","unstructured":"Strain JF, Didehbani N, Spence J, Conover H, Bartz EK, Mansinghani S, et al. White matter changes and confrontation naming in retired aging National Football League athletes. J Neurotrauma. 2017;34(2):372\u20139. https:\/\/doi.org\/10.1089\/neu.2016.4446.","journal-title":"J Neurotrauma"},{"issue":"11","key":"2195_CR2","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1002\/hbm.23278","volume":"37","author":"MA Lancaster","year":"2016","unstructured":"Lancaster MA, Olson DV, McCrea MA, Nelson LD, LaRoche AA, Muftuler LT. Acute white matter changes following sport-related concussion: a serial diffusion tensor and diffusion kurtosis tensor imaging study. Hum Brain Mapp. 2016;37(11):3821\u201334. https:\/\/doi.org\/10.1002\/hbm.23278.","journal-title":"Hum Brain Mapp"},{"key":"2195_CR3","doi-asserted-by":"publisher","first-page":"fcz021","DOI":"10.1093\/braincomms\/fcz021","volume":"1","author":"AA Champagne","year":"2019","unstructured":"Champagne AA, Peponoulas E, Terem I, Ross A, Tayebi M, Chen Y, et al. Novel strain analysis informs about injury susceptibility of the corpus callosum to repeated impacts. Brain Commun. 2019;1:fcz021.","journal-title":"Brain Commun"},{"key":"2195_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.neuint.2017.01.019","volume":"111","author":"N Sen","year":"2017","unstructured":"Sen N. An insight into the vision impairment following traumatic brain injury. Neurochem Int. 2017;111:103\u20137. https:\/\/doi.org\/10.1016\/j.neuint.2017.01.019.","journal-title":"Neurochem Int"},{"issue":"6","key":"2195_CR5","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/cxo.12670","volume":"101","author":"RA Armstrong","year":"2018","unstructured":"Armstrong RA. Visual problems associated with traumatic brain injury. Clin Exp Optom. 2018;101(6):716\u201326. https:\/\/doi.org\/10.1111\/cxo.12670.","journal-title":"Clin Exp Optom"},{"issue":"1","key":"2195_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3233\/VES-170607","volume":"27","author":"WG Wright","year":"2017","unstructured":"Wright WG, Tierney RT, McDevitt J. Visual-vestibular processing deficits in mild traumatic brain injury. J Vestib Res. 2017;27(1):27\u201337. https:\/\/doi.org\/10.3233\/VES-170607.","journal-title":"J Vestib Res"},{"key":"2195_CR7","doi-asserted-by":"publisher","first-page":"e00454","DOI":"10.1002\/brb3.454","volume":"6","author":"CS Gilmore","year":"2016","unstructured":"Gilmore CS, Camchong J, Davenport ND, Nelson NW, Kardon RH, Lim KO, et al. Deficits in visual system functional connectivity after blast-related mild TBI are associated with injury severity and executive dysfunction. Brain Behav. 2016;6:e00454.","journal-title":"Brain Behav"},{"issue":"4","key":"2195_CR8","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1682\/JRRD.2013.02.0049","volume":"51","author":"GL Goodrich","year":"2014","unstructured":"Goodrich GL, Martinsen GL, Flyg HM, Kirby J, Garvert DW, Tyler CW. Visual function, traumatic brain injury, and posttraumatic stress disorder. J Rehabil Res Dev. 2014;51(4):547\u201358. https:\/\/doi.org\/10.1682\/JRRD.2013.02.0049.","journal-title":"J Rehabil Res Dev"},{"issue":"14","key":"2195_CR9","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1089\/neu.2016.4870","volume":"34","author":"H Chen","year":"2017","unstructured":"Chen H, Desai A, Kim HY. Repetitive closed-head impact model of engineered rotational acceleration induces long-term cognitive impairments with persistent astrogliosis and microgliosis in mice. J Neurotrauma. 2017;34(14):2291\u2013302. https:\/\/doi.org\/10.1089\/neu.2016.4870.","journal-title":"J Neurotrauma"},{"issue":"5","key":"2195_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197346","volume":"13","author":"NK Evanson","year":"2018","unstructured":"Evanson NK, Guilhaume-Correa F, Herman JP, Goodman MD. Optic tract injury after closed head traumatic brain injury in mice: a model of indirect traumatic optic neuropathy. PLoS One. 2018;13(5):e0197346. https:\/\/doi.org\/10.1371\/journal.pone.0197346.","journal-title":"PLoS One"},{"issue":"2","key":"2195_CR11","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1089\/neu.2019.6602","volume":"37","author":"A Desai","year":"2020","unstructured":"Desai A, Chen H, Kim HY. Multiple mild traumatic brain injuries lead to visual dysfunction in a mouse model. J Neurotrauma. 2020;37(2):286\u201394. https:\/\/doi.org\/10.1089\/neu.2019.6602.","journal-title":"J Neurotrauma"},{"key":"2195_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mam.2018.03.004","volume":"64","author":"HY Kim","year":"2018","unstructured":"Kim HY, Spector AA. N-Docosahexaenoylethanolamine: a neurotrophic and neuroprotective metabolite of docosahexaenoic acid. Mol Asp Med. 2018;64:34\u201344. https:\/\/doi.org\/10.1016\/j.mam.2018.03.004.","journal-title":"Mol Asp Med"},{"issue":"1","key":"2195_CR13","doi-asserted-by":"publisher","first-page":"13123","DOI":"10.1038\/ncomms13123","volume":"7","author":"JW Lee","year":"2016","unstructured":"Lee JW, Huang BX, Kwon H, Rashid MA, Kharebava G, Desai A, et al. Orphan GPR110 (ADGRF1) targeted by N-docosahexaenoylethanolamine in development of neurons and cognitive function. Nat Commun. 2016;7(1):13123. https:\/\/doi.org\/10.1038\/ncomms13123.","journal-title":"Nat Commun"},{"issue":"1","key":"2195_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s42003-020-0831-6","volume":"3","author":"BX Huang","year":"2020","unstructured":"Huang BX, Hu X, Kwon HS, Fu C, Lee JW, Southall N, et al. Synaptamide activates the adhesion GPCR GPR110 (ADGRF1) through GAIN domain binding. Commun Biol. 2020;3(1):109. https:\/\/doi.org\/10.1038\/s42003-020-0831-6.","journal-title":"Commun Biol"},{"issue":"6","key":"2195_CR15","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/jnc.12255","volume":"125","author":"MA Rashid","year":"2013","unstructured":"Rashid MA, Katakura M, Kharebava G, Kevala K, Kim HY. N-Docosahexaenoylethanolamine is a potent neurogenic factor for neural stem cell differentiation. J Neurochem. 2013;125(6):869\u201384. https:\/\/doi.org\/10.1111\/jnc.12255.","journal-title":"J Neurochem"},{"issue":"1","key":"2195_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12974-016-0751-z","volume":"13","author":"T Park","year":"2016","unstructured":"Park T, Chen H, Kevala K, Lee JW, Kim HY. N-Docosahexaenoylethanolamine ameliorates LPS-induced neuroinflammation via cAMP\/PKA-dependent signaling. J Neuroinflammation. 2016;13(1):284. https:\/\/doi.org\/10.1186\/s12974-016-0751-z.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"2195_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12974-019-1621-2","volume":"16","author":"T Park","year":"2019","unstructured":"Park T, Chen H, Kim HY. GPR110 (ADGRF1) mediates anti-inflammatory effects of N-docosahexaenoylethanolamine. J Neuroinflammation. 2019;16(1):225. https:\/\/doi.org\/10.1186\/s12974-019-1621-2.","journal-title":"J Neuroinflammation"},{"key":"2195_CR18","doi-asserted-by":"crossref","unstructured":"Kwon H, Kevala K, Xin H, Patnaik S, Marugan J, Kim H-Y. Ligand-induced GPR110 activation facilitates axon growth after Injury. Int J Mol Sci. 2021;22:3386.","DOI":"10.3390\/ijms22073386"},{"issue":"1","key":"2195_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1750-1326-9-55","volume":"9","author":"DR Namjoshi","year":"2014","unstructured":"Namjoshi DR, Cheng WH, McInnes KA, Martens KM, Carr M, Wilkinson A, et al. Merging pathology with biomechanics using CHIMERA (Closed-Head Impact Model of Engineered Rotational Acceleration): a novel, surgery-free model of traumatic brain injury. Mol Neurodegener. 2014;9(1):55. https:\/\/doi.org\/10.1186\/1750-1326-9-55.","journal-title":"Mol Neurodegener"},{"key":"2195_CR20","doi-asserted-by":"publisher","unstructured":"Benchorin G, Calton MA, Beaulieu MO, Vollrath D. Assessment of murine retinal function by electroretinography. Bio Protoc. 2017;7(7). https:\/\/doi.org\/10.21769\/BioProtoc.2218.","DOI":"10.21769\/BioProtoc.2218"},{"issue":"12","key":"2195_CR21","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1038\/jcbfm.2013.146","volume":"33","author":"G Wang","year":"2013","unstructured":"Wang G, Zhang J, Hu X, Zhang L, Mao L, Jiang X, et al. Microglia\/macrophage polarization dynamics in white matter after traumatic brain injury. J Cereb Blood Flow Metab. 2013;33(12):1864\u201374. https:\/\/doi.org\/10.1038\/jcbfm.2013.146.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"2195_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/ana.24064","volume":"75","author":"BC Mouzon","year":"2014","unstructured":"Mouzon BC, Bachmeier C, Ferro A, Ojo JO, Crynen G, Acker CM, et al. Chronic neuropathological and neurobehavioral changes in a repetitive mild traumatic brain injury model. Ann Neurol. 2014;75(2):241\u201354. https:\/\/doi.org\/10.1002\/ana.24064.","journal-title":"Ann Neurol"},{"issue":"Pt 3","key":"2195_CR23","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.expneurol.2015.08.018","volume":"275","author":"DJ Loane","year":"2016","unstructured":"Loane DJ, Kumar A. Microglia in the TBI brain: the good, the bad, and the dysregulated. Exp Neurol. 2016;275(Pt 3):316\u201327. https:\/\/doi.org\/10.1016\/j.expneurol.2015.08.018.","journal-title":"Exp Neurol"},{"key":"2195_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fnint.2016.00007","volume":"10","author":"VS Sajja","year":"2016","unstructured":"Sajja VS, Hlavac N, VandeVord PJ. Role of glia in memory deficits following traumatic brain injury: biomarkers of glia dysfunction. Front Integr Neurosci. 2016;10:7.","journal-title":"Front Integr Neurosci"},{"issue":"6","key":"2195_CR25","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/0892-0362(94)90033-7","volume":"16","author":"JS de Olmos","year":"1994","unstructured":"de Olmos JS, Beltramino CA, de Olmos de Lorenzo S. Use of an amino-cupric-silver technique for the detection of early and semiacute neuronal degeneration caused by neurotoxicants, hypoxia, and physical trauma. Neurotoxicol Teratol. 1994;16(6):545\u201361. https:\/\/doi.org\/10.1016\/0892-0362(94)90033-7.","journal-title":"Neurotoxicol Teratol"},{"issue":"12","key":"2195_CR26","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.tips.2010.09.005","volume":"31","author":"DJ Loane","year":"2010","unstructured":"Loane DJ, Faden AI. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci. 2010;31(12):596\u2013604. https:\/\/doi.org\/10.1016\/j.tips.2010.09.005.","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"2195_CR27","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/MCC.0b013e3280895d5c","volume":"13","author":"JW Schouten","year":"2007","unstructured":"Schouten JW. Neuroprotection in traumatic brain injury: a complex struggle against the biology of nature. Curr Opin Crit Care. 2007;13(2):134\u201342. https:\/\/doi.org\/10.1097\/MCC.0b013e3280895d5c.","journal-title":"Curr Opin Crit Care"},{"issue":"1","key":"2195_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2407-10-40","volume":"10","author":"AM Lum","year":"2010","unstructured":"Lum AM, Wang BB, Beck-Engeser GB, Li L, Channa N, Wabl M. Orphan receptor GPR110, an oncogene overexpressed in lung and prostate cancer. BMC Cancer. 2010;10(1):40. https:\/\/doi.org\/10.1186\/1471-2407-10-40.","journal-title":"BMC Cancer"},{"issue":"12","key":"2195_CR29","doi-asserted-by":"publisher","first-page":"745","DOI":"10.21037\/atm-20-3146","volume":"8","author":"B Ma","year":"2020","unstructured":"Ma B, Zhu J, Su J, Pan F, Ji Y, Luan L, et al. The role of GPR110 in lung cancer progression. Ann Transl Med. 2020;8(12):745. https:\/\/doi.org\/10.21037\/atm-20-3146.","journal-title":"Ann Transl Med"},{"issue":"3","key":"2195_CR30","first-page":"433","volume":"7","author":"B Ma","year":"2017","unstructured":"Ma B, Zhu J, Tan J, Mao Y, Tang L, Shen C, et al. Gpr110 deficiency decelerates carcinogen-induced hepatocarcinogenesis via activation of the IL-6\/STAT3 pathway. Am J Cancer Res. 2017;7(3):433\u201347.","journal-title":"Am J Cancer Res"},{"issue":"4","key":"2195_CR31","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nrd2518","volume":"7","author":"MC Lagerstr\u00f6m","year":"2008","unstructured":"Lagerstr\u00f6m MC, Schi\u00f6th HB. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov. 2008;7(4):339\u201357. https:\/\/doi.org\/10.1038\/nrd2518.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2195_CR32","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1146\/annurev-pharmtox-010617-052933","volume":"58","author":"RH Purcell","year":"2018","unstructured":"Purcell RH, Hall RA. Adhesion G protein-coupled receptors as drug targets. Annu Rev Pharmacol Toxicol. 2018;58(1):429\u201349. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010617-052933.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"16","key":"2195_CR33","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1007\/s00018-007-7067-1","volume":"64","author":"TK Bjarnad\u00f3ttir","year":"2007","unstructured":"Bjarnad\u00f3ttir TK, Fredriksson R, Schi\u00f6th HB. The adhesion GPCRs: a unique family of G protein-coupled receptors with important roles in both central and peripheral tissues. Cell Mol Life Sci. 2007;64(16):2104\u201319. https:\/\/doi.org\/10.1007\/s00018-007-7067-1.","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"2195_CR34","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.tibs.2008.07.005","volume":"33","author":"S Yona","year":"2008","unstructured":"Yona S, Lin HH, Siu WO, Gordon S, Stacey M. Adhesion-GPCRs: emerging roles for novel receptors. Trends Biochem Sci. 2008;33(10):491\u2013500. https:\/\/doi.org\/10.1016\/j.tibs.2008.07.005.","journal-title":"Trends Biochem Sci"},{"issue":"24","key":"2195_CR35","doi-asserted-by":"publisher","first-page":"9703","DOI":"10.3390\/ijms21249703","volume":"21","author":"A Tyrtyshnaia","year":"2020","unstructured":"Tyrtyshnaia A, Bondar A, Konovalova S, Sultanov R, Manzhulo I. N -Docosahexanoylethanolamine reduces microglial activation and improves hippocampal plasticity in a murine model of neuroinflammation. Int J Mol Sci. 2020;21(24):9703. https:\/\/doi.org\/10.3390\/ijms21249703.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2195_CR36","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/s41598-020-80818-9","volume":"11","author":"I Ponomarenko Arina","year":"2021","unstructured":"Ponomarenko Arina I, Tyrtyshnaia Anna A, Pislyagin Evgeny A, Dyuizen Inessa V, Sultanov Ruslan M, Manzhulo Igor V. N-docosahexaenoylethanolamine reduces neuroinflammation and cognitive impairment after mild traumatic brain injury in rats. Sci Rep. 2021;11(1):756. https:\/\/doi.org\/10.1038\/s41598-020-80818-9.","journal-title":"Sci Rep"},{"issue":"3","key":"2195_CR37","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1001\/jamaneurol.2014.3558","volume":"72","author":"KN Corps","year":"2015","unstructured":"Corps KN, Roth TL, McGavern DB. Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol. 2015;72(3):355\u201362. https:\/\/doi.org\/10.1001\/jamaneurol.2014.3558.","journal-title":"JAMA Neurol"},{"key":"2195_CR38","doi-asserted-by":"crossref","unstructured":"Dinet VP, KG Badaut J. Brain\u2013immune interactions and neuroinflammation after traumatic brain injury. Front Neurosci. 2019;13:1178.","DOI":"10.3389\/fnins.2019.01178"},{"key":"2195_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fimmu.2016.00123","volume":"7","author":"VKB Raker","year":"2016","unstructured":"Raker VKB, C.; Steinbrink, K. The cAMP pathway as therapeutic target in autoimmune and inflammatory diseases. Front Immunol. 2016;7:123.","journal-title":"Front Immunol"},{"issue":"6","key":"2195_CR40","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.3171\/2014.7.JNS14272","volume":"121","author":"R Mannix","year":"2014","unstructured":"Mannix R, Berglass J, Berkner J, Moleus P, Qiu J, Andrews N, et al. Chronic gliosis and behavioral deficits in mice following repetitive mild traumatic brain injury. J Neurosurg. 2014;121(6):1342\u201350. https:\/\/doi.org\/10.3171\/2014.7.JNS14272.","journal-title":"J Neurosurg"},{"issue":"2","key":"2195_CR41","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/brain\/awx350","volume":"141","author":"CA Tagge","year":"2018","unstructured":"Tagge CA, Fisher AM, Minaeva OV, Gaudreau-Balderrama A, Moncaster JA, Zhang XL, et al. Concussion, microvascular injury, and early tauopathy in young athletes after impact head injury and an impact concussion mouse model. Brain. 2018;141(2):422\u201358. https:\/\/doi.org\/10.1093\/brain\/awx350.","journal-title":"Brain"},{"key":"2195_CR42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.expneurol.2019.02.012","volume":"317","author":"C Vonder Haar","year":"2019","unstructured":"Vonder Haar C, Martens KM, Bashir A, McInnes KA, Cheng WH, Cheung H, et al. Repetitive closed-head impact model of engineered rotational acceleration (CHIMERA) injury in rats increases impulsivity, decreases dopaminergic innervation in the olfactory tubercle and generates white matter inflammation, tau phosphorylation and degeneration. Exp Neurol. 2019;317:87\u201399. https:\/\/doi.org\/10.1016\/j.expneurol.2019.02.012.","journal-title":"Exp Neurol"},{"issue":"3","key":"2195_CR43","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3174\/ajnr.A0856","volume":"29","author":"DR Rutgers","year":"2008","unstructured":"Rutgers DR, Toulgoat F, Cazejust J, Fillard P, Lasjaunias P, Ducreux D. White matter. abnormalities in mild traumatic brain injury: a diffusion tensor imaging study. Am J Neuroradiol. 2008;29(3):514\u20139. https:\/\/doi.org\/10.3174\/ajnr.A0856.","journal-title":"Am J Neuroradiol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-021-02195-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-021-02195-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-021-02195-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T16:02:46Z","timestamp":1626537766000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-021-02195-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,17]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2195"],"URL":"https:\/\/doi.org\/10.1186\/s12974-021-02195-y","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,17]]},"assertion":[{"value":"15 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}